A new ADC drug for the treatment of acute lymphoblastic leukemia――BESPONSA

doi:10.3969/j.issn.1672-3384.2017.11.003

PDF(616 KB)

Clinical Medication Journal ›› 2017, Vol. 15 ›› Issue (11) : 9-14. DOI: 10.3969/j.issn.1672-3384.2017.11.003

A new ADC drug for the treatment of acute lymphoblastic leukemia――BESPONSA

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2017, 15(11): 9-14 https://doi.org/10.3969/j.issn.1672-3384.2017.11.003

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(616 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2017-10-11	2017-11-28
Issue Date
2017-11-28

Please choose a citation manager

Content to export